T1	SNP 26 34	c.538G>A
T2	SNP 36 41	G180R
R1	Equiv Arg1:T2 Arg2:T1	
T3	Organic_inorganic_molecules_affected 36 41	G180R
E1	Organic_inorganic_molecules_affected:T3 Theme:T4 Agent:T2
T4	Entity 36 40	G180
T5	Entity 46 52	ABCC11
R2	SNP_coupled_gene Arg1:T2 Arg2:T5	
T6	Entity 31 34	G>A
R3	Nucleotide_substitution Arg1:T1 Arg2:T6	
T7	Neg 56 59	not
T8	Association 60 70	associated
E2	Association:T8 bc:T9 snp_int:T2
R4	Negation_marker Arg1:E2 Arg2:T7	
T9	Cancer 76 89	breast cancer
T10	Entity 98 107	Europeans
R5	Population_assignment Arg1:T2 Arg2:T10	
T11	Organic_inorganic_molecules_affected 11 21	associated
E3	Organic_inorganic_molecules_affected:T11 Theme:T12 Agent:T1
T12	Entity 4 10	earwax
T13	SNP 110 131	Genetic polymorphisms
T14	Entity 135 162	human ABC-transporter genes
R6	SNP_coupled_gene Arg1:T13 Arg2:T14	
R7	Member Arg1:T14 Arg2:T5	
T15	Spec 173 182	suggested
T16	Association 186 194	modulate
E4	Association:T16 bc:T17 snp_int:T13
T17	Cancer 195 208	breast cancer
R8	Speculation_marker Arg1:E4 Arg2:T15	
T18	Entity 255 261	ABCC11
T19	Entity 263 267	MRP8
R10	Equiv Arg1:T18 Arg2:T19	
T20	Entity 548 556	G-allele
T21	SNP 564 572	c.538G>A
T22	Entity 566 569	538
T23	Entity 569 572	G>A
T24	Entity 28 31	538
R9	SNP_location Arg1:T1 Arg2:T24	
T25	Organic_inorganic_molecules_affected 537 547	associated
E5	Organic_inorganic_molecules_affected:T25 Theme:T26 Agent:T21
T26	Entity 526 536	wet earwax
R11	SNP_location Arg1:T21 Arg2:T22	
R12	Nucleotide_substitution Arg1:T21 Arg2:T23	
R13	SNP_allele Arg1:T21 Arg2:T20	
T27	Association 619 623	risk
E6	Association:T27 bc:T29 snp_int:T21
A1	Effect_Type E6 Increase
T28	Effect_Type 609 618	increased
R14	Effect_type_marker Arg1:E6 Arg2:T28	
T29	Cancer 628 641	breast cancer
T30	Entity 645 659	Japanese women
R15	Population_assignment Arg1:T21 Arg2:T30	
T31	Neg 674 676	no
T32	Spec 677 685	evidence
T33	Association 698 709	association
E7	Association:T33 bc:T29 snp_int:T35
R16	Speculation_marker Arg1:E7 Arg2:T32	
R17	Negation_marker Arg1:E7 Arg2:T31	
T34	Entity 731 746	Caucasian women
T35	SNP 564 572	c.538G>A
R18	SNP_allele Arg1:T35 Arg2:T20	
R19	SNP_location Arg1:T35 Arg2:T22	
R20	Nucleotide_substitution Arg1:T35 Arg2:T23	
R21	Population_assignment Arg1:T35 Arg2:T34	
T36	Association 779 790	association
E8	Association:T36 snp_int:T37 bc:T41
T37	SNP 798 806	c.538G>A
T38	Entity 818 824	ABCC11
R22	SNP_coupled_gene Arg1:T37 Arg2:T38	
R23	SNP_coupled_gene Arg1:T35 Arg2:T18	
R24	SNP_coupled_gene Arg1:T21 Arg2:T18	
T39	Entity 800 803	538
T40	Entity 803 806	G>A
R25	Nucleotide_substitution Arg1:T37 Arg2:T40	
R26	SNP_location Arg1:T37 Arg2:T39	
T41	Cancer 830 843	breast cancer
T42	Spec 760 774	confirm/refute
R27	Speculation_marker Arg1:E8 Arg2:T42	
T43	Entity 946 964;970 977	case-control study Germany
R28	Population_assignment Arg1:T37 Arg2:T43	
T44	Neg 1031 1033	No
T45	Association 1034 1045	association
E9	Association:T45 snp_int:T46
R29	Negation_marker Arg1:E9 Arg2:T44	
T46	SNP 1089 1095	538G>A
T47	Entity 1089 1092	538
T48	Entity 1092 1095	G>A
T49	Entity 1107 1113	ABCB11
R30	SNP_location Arg1:T46 Arg2:T47	
R31	Nucleotide_substitution Arg1:T46 Arg2:T48	
R32	SNP_coupled_gene Arg1:T46 Arg2:T49	
T50	Cancer 1119 1132	breast cancer
R33	Equiv Arg1:T46 Arg2:T50	
T51	Spec 1158 1165	suggest
T52	SNP 1175 1183	c.538G>A
T53	Entity 1197 1203	ABCC11
R34	SNP_coupled_gene Arg1:T52 Arg2:T53	
T54	Entity 1177 1180	538
T55	Entity 1180 1183	G>A
R35	SNP_coupled_gene Arg1:T52 Arg2:T55	
R36	SNP_location Arg1:T52 Arg2:T54	
T56	Neg 1209 1212	not
T57	Association 1213 1223	contribute
E10	Association:T57 bc:T58 snp_int:T52
T58	Cancer 1227 1248	breast carcinogenesis
T59	Entity 1252 1257;1261 1277	women European descent
R37	Equiv Arg1:T34 Arg2:T59	
R38	Negation_marker Arg1:E10 Arg2:T56	
R39	Speculation_marker Arg1:E10 Arg2:T51	
R40	Population_assignment Arg1:T52 Arg2:T59	
A2	SNP_Type T2 Missense
A3	SNP_Type T21 Missense
A4	SNP_Type T35 Missense
A5	SNP_Type T37 Missense
A6	SNP_Type T46 Missense
A7	SNP_Type T52 Missense
